Vaxcyte, Inc. (PCVX) NASDAQ

46.07

-1.63(-3.42%)

Updated at December 04 04:00PM

Currency In USD

Valuation

Market Cap9.99B
Enterprise Value9.67B
P/E Ratio-9.39
PEG Ratio0.54
Price/Sales Ratio0
Price/Book Ratio2.13
Enterprise/Revenue0
Enterprise/EBITDA-9.07

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.21

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA-448.08M
Net Income-463.93M
Diluted EPS-3.8

Balance Sheet

Total Cash1.71B
Total Cash/Share12.57
Total Debt84.44M
Total Debt/Equity0.03
Current Ratio8.83
Book Value Per Share21.24

Price History

52-Week Change-51.28
52-Week High94.6
52-Week Low27.66
Moving Average 50 Days43.32
Moving Average 200 Days41.35

Statistics

Average Volume1.74M
Shares Outstanding130.9M
% Held by Institutions103.84

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A